BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 35973562)

  • 1. The role of sphingolipids in meibomian gland dysfunction and ocular surface inflammation.
    Paranjpe V; Galor A; Grambergs R; Mandal N
    Ocul Surf; 2022 Oct; 26():100-110. PubMed ID: 35973562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition.
    Paranjpe V; Tan J; Nguyen J; Lee J; Allegood J; Galor A; Mandal N
    Ocul Surf; 2019 Apr; 17(2):318-326. PubMed ID: 30553001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between ocular surface sphingomyelinases, Meibum and Tear Sphingolipids, and clinical parameters of meibomian gland dysfunction.
    Sanchez V; Galor A; Jensen K; Mondal K; Mandal N
    Ocul Surf; 2022 Jul; 25():101-107. PubMed ID: 35714913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meibum sphingolipid composition is altered in individuals with meibomian gland dysfunction-a side by side comparison of Meibum and Tear Sphingolipids.
    Galor A; Sanchez V; Jensen A; Burton M; Maus K; Stephenson D; Chalfant C; Mandal N
    Ocul Surf; 2022 Jan; 23():87-95. PubMed ID: 34861426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Bioactive Sphingolipids in Inflammation and Eye Diseases.
    Mondal K; Mandal N
    Adv Exp Med Biol; 2019; 1161():149-167. PubMed ID: 31562629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
    Hait NC; Maiti A
    Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
    Tabuchi K; Hara A
    Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids in inflammation: pathological implications and potential therapeutic targets.
    Nixon GF
    Br J Pharmacol; 2009 Oct; 158(4):982-93. PubMed ID: 19563535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
    Ayub M; Jin HK; Bae JS
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory Ocular Diseases and Sphingolipid Signaling.
    Grambergs R; Mondal K; Mandal N
    Adv Exp Med Biol; 2019; 1159():139-152. PubMed ID: 31502203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of bioactive sphingolipids in physiology and pathology.
    Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
    Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in cancer.
    Furuya H; Shimizu Y; Kawamori T
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):567-76. PubMed ID: 22005951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids in inflammation: roles and implications.
    Pettus BJ; Chalfant CE; Hannun YA
    Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate.
    Gomez-Muñoz A; Presa N; Gomez-Larrauri A; Rivera IG; Trueba M; Ordoñez M
    Prog Lipid Res; 2016 Jan; 61():51-62. PubMed ID: 26703189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
    Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
    Front Immunol; 2021; 12():635704. PubMed ID: 34054805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
    Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
    Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: Standard operating procedures.
    Ambaw YA; Timbadia DP; Raida M; Torta F; Wenk MR; Tong L
    Ocul Surf; 2022 Oct; 26():318-327. PubMed ID: 33022413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate and ceramide-1-phosphate promote migration, pro-inflammatory and pro-fibrotic responses in retinal pigment epithelium cells.
    Simón MV; Vera MS; Tenconi PE; Soto T; Prado Spalm FH; Torlaschi C; Mateos MV; Rotstein NP
    Exp Eye Res; 2022 Nov; 224():109222. PubMed ID: 36041511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.
    Oskouian B; Saba J
    Cell Cycle; 2007 Mar; 6(5):522-7. PubMed ID: 17361098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.